An Iranian researcher has contributed to new findings in the field of cancer diagnosis and treatment through a study examining innovative approaches to molecular imaging and theranostics, a rapidly developing area of precision medicine. This was reported by
Pars Today, a TV BRICS partner.
According to Bushehr University of Medical Sciences, the research was conducted by Majid Assadi, Professor of Radiology and Nuclear Medicine and Head of the Persian Gulf Nuclear Medicine Research Centre. The study focuses on emerging techniques that combine advanced diagnostic imaging with targeted therapies to improve the detection and treatment of cancer.
Researchers say the work investigates new strategies for identifying tumours at earlier stages and delivering more personalised treatments tailored to individual patients. The approach is part of a broader shift towards precision medicine, which aims to improve outcomes by matching therapies to the specific biological characteristics of a disease.
University officials said the study opens new perspectives for the development of targeted cancer therapies and could contribute to ongoing efforts to make treatment more effective while reducing unnecessary interventions.
Shokrollah Farrokhi, Vice-Chancellor for Research and Technology at Bushehr University of Medical Sciences, described the research as the result of years of scientific work, international collaboration and sustained engagement with developments at the forefront of oncology research.
Experts cited by Iranian media said the study represents an important contribution to advanced cancer research and reflects growing scientific activity in areas such as molecular imaging, nuclear medicine and personalised treatment strategies.
The findings also underscore the increasing importance of theranostics in modern oncology. By integrating diagnostic and therapeutic methods into a single framework, the field is expected to play a larger role in the future of cancer care, helping physicians deliver more targeted and individualised treatments.